Outcomes have been assessed from eight several hours to nine weeks following randomization. Three of the five trials had been judged to have a significant possibility of bias and the other two as unclear hazard. Three studies (nabiximols, dronabinol) confirmed no outcome applying validated symptom scales. 1 review that evaluated https://convertingiratogold44332.59bloggers.com/33349838/the-5-second-trick-for-tetrahydrocannabinol-thc